Bruno Carlos
Sangro Gómez-Acebo
Catedrático de Universidad
University Medical Center
Lubbock, Estados UnidosPublications in collaboration with researchers from University Medical Center (1)
2023
-
Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)
Future oncology (London, England), Vol. 19, Núm. 38, pp. 2505-2516